HB 2945 Oklahoma House · 2026 Regular Session

Abortion-inducing drugs; Protecting Moms and Babies Act; terms; exclusions; manufacture or distribute; mail, transport, deliver, prescribe, or provide; exception; qui tam actions; enforcement of prohibitions; defenses; statute of limitation; remedies; personal jurisdiction and applicability of state law; jurisdiction of appeals; protections from counteractions; severability clause; effective date.

HB 2945, the "Protecting Moms and Babies Act," prohibits manufacturing, distributing, mailing, transporting, prescribing, or providing abortion-inducing drugs in Oklahoma, with specific exceptions for medical treatments like ectopic pregnancy or miscarriage. It allows only private citizens (via "qui tam" lawsuits) to enforce the ban, not state officials, and explicitly prohibits lawsuits against pregnant women seeking abortion or common carriers transporting patients (if unaware of intent). The law defines "abortion-inducing drugs" to include medications like Mifeprex and misoprostol, excluding use for non-abortion medical purposes. Key exceptions permit the drug's use solely to preserve a mother's life, treat ectopic pregnancy, or address miscarriage-related complications.
Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2026
Committee Review
Floor Vote
Governor
Introduced Feb 2, 2026 Last action Feb 3, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
4
Key actions
0
Committee
1
Feb 3, 2026
Committee
Referred to Civil Judiciary
lower
Feb 2, 2026
Introduced
First Reading
lower
2 primary · 0 co-sponsors

Sponsors